Congenital epulis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:157826K06.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital epulis, also known as congenital granular cell epulis or congenital gingival granular cell tumor, is a rare benign soft tissue tumor that is present at birth. It arises from the gingiva (gum tissue) of newborns, appearing as a pedunculated (stalk-like) mass protruding from the alveolar ridge of the upper or lower jaw, though the maxilla (upper jaw) is more commonly affected. The tumor predominantly affects female neonates, with a female-to-male ratio of approximately 8-10:1. The mass can vary in size from a few millimeters to several centimeters and may be single or, less commonly, multiple. The primary clinical concern with congenital epulis is its potential to interfere with feeding and breathing, particularly when the mass is large enough to obstruct the oral cavity. Despite its sometimes alarming appearance, the tumor is entirely benign and does not undergo malignant transformation. Histologically, it is composed of large cells with granular eosinophilic cytoplasm, but unlike adult granular cell tumors, congenital epulis is typically negative for S-100 protein immunostaining, suggesting a different histogenesis. The standard treatment is surgical excision, which is usually curative. The procedure is generally straightforward, especially for pedunculated lesions, and recurrence after complete removal is extremely rare. In some cases, particularly with smaller lesions, spontaneous regression has been reported, and conservative observation may be considered. No additional therapy is required following excision, and the long-term prognosis is excellent with no impact on subsequent dental development or overall health.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Congenital epulis.

View clinical trials →

No actively recruiting trials found for Congenital epulis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Congenital epulis community →

No specialists are currently listed for Congenital epulis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Congenital epulis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital epulisForum →

No community posts yet. Be the first to share your experience with Congenital epulis.

Start the conversation →

Latest news about Congenital epulis

No recent news articles for Congenital epulis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Congenital epulis

What is Congenital epulis?

Congenital epulis, also known as congenital granular cell epulis or congenital gingival granular cell tumor, is a rare benign soft tissue tumor that is present at birth. It arises from the gingiva (gum tissue) of newborns, appearing as a pedunculated (stalk-like) mass protruding from the alveolar ridge of the upper or lower jaw, though the maxilla (upper jaw) is more commonly affected. The tumor predominantly affects female neonates, with a female-to-male ratio of approximately 8-10:1. The mass can vary in size from a few millimeters to several centimeters and may be single or, less commonly,

How is Congenital epulis inherited?

Congenital epulis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Congenital epulis typically begin?

Typical onset of Congenital epulis is neonatal. Age of onset can vary across affected individuals.